Business Context and Reporting Period
The provided filing is Blade Air Mobility, Inc.’s unaudited Form 10-Q for the three months ended March 31, 2022, although the request metadata identifies Strata Critical Medical, Inc. Blade operates an asset-light air mobility platform using contracted aircraft operators across Short Distance, MediMobility Organ Transport and Jet, and Other businesses. The company changed its fiscal year-end from September 30 to December 31 effective in 2022.
Key Financial Metrics
| Metric | Q1 2022 | Q1 2021 | Change |
|---|---|---|---|
| Revenue | $26.6 million | $9.3 million | +187% |
| Cost of revenue | $23.7 million | $7.8 million | +204% |
| Gross profit | $2.9 million | $1.5 million | Gross margin declined to approximately 11% from 16% |
| Operating loss | $(13.7) million | $(4.2) million | Operating margin approximately (51)% versus (46)% |
| Net loss | $(11.0) million | $(4.2) million | Loss per share was $(0.16) in both periods |
| Operating cash flow | $(10.1) million | $(0.6) million | Greater cash usage |
| Cash, cash equivalents and restricted cash | $4.2 million | $7.9 million | Period-end balance |
| Short-term investments | $266.6 million | Not clearly provided in the filing excerpt | Available for liquidity needs |
Revenue growth was driven primarily by the September 2021 acquisition of Trinity Air Medical, the November 2021 acquisition of exclusive Helijet routes in Canada, and organic growth. MediMobility Organ Transport and Jet revenue increased 186% to $22.1 million, while Short Distance revenue increased 300% to $4.2 million. Seats flown on passenger flights increased to 18,494 from 2,255.
General and administrative expense increased 190% to $14.0 million, reflecting higher staffing, public-company costs, legal and regulatory advocacy fees, directors’ and officers’ insurance, amortization, and merger-and-acquisition-related professional fees. Stock-based compensation was $2.1 million.
The company had no conventional debt reported. It had $28.8 million of warrant liabilities and operating lease liabilities totaling approximately $1.0 million. Total liabilities were $45.2 million and stockholders’ equity was $281.5 million at March 31, 2022.
Material Changes Versus the Prior Comparable Period
- Revenue increased by $17.4 million, or 187%, largely from acquisitions and growth in organ transport, jet, and Short Distance services.
- Cost of revenue grew faster than revenue, and gross margin declined because the reintroduced airport-transfer service was operating below breakeven during its ramp-up and Omicron reduced Vancouver demand.
- Operating loss increased by $9.5 million, reflecting substantially higher operating expenses and continued investment in growth.
- Net cash used in operating activities increased to $10.1 million from $0.6 million.
- Investing activities provided $11.0 million, primarily from $11.7 million of proceeds from sales of short-term investments.
- The fair value of warrant liabilities declined by $2.6 million, producing non-cash other income and partially offsetting the operating loss.
- The company reported a material weakness in internal control over financial reporting and concluded that its disclosure controls and procedures were ineffective as of March 31, 2022.
Guidance, Outlook, Risks and Unusual Items
Management expects net losses to continue in the short term but believes existing cash, restricted cash, and short-term investments are sufficient to meet current operational needs for at least the next 12 months. Management stated that no additional capital is expected to be required for the current business plan over that period, subject to factors including expansion, acquisitions, customer demand, capital expenditures, and electric vertical aircraft adoption.
The company expects seasonal strength in the second and third quarters, although the filing notes that the first quarter was affected by the Omicron variant. Key risks include COVID-19-related travel disruptions, demand and pricing pressure, aircraft operator availability and performance, aviation regulation, safety events, technology failures and cyberattacks, insurance availability, competition, international expansion, acquisition integration, and the timing and certification of electric vertical aircraft.
As of March 31, 2022, unfulfilled capacity purchase obligations were approximately $4.1 million for 2022, $8.0 million for 2023, and $1.1 million for 2024. Certain obligations could be terminated upon government-imposed travel restrictions or with notice. In April 2022, an amended operator agreement increased obligations by approximately $6.0 million in 2023, $0.6 million in 2024, and $6.0 million in 2025, with termination rights upon 60 days’ notice.
The Shoreline Aviation litigation was dismissed with prejudice on March 16, 2022, with no admission of wrongdoing or liability by the Blade defendants. The filing states that no other pending litigation is expected to materially affect the company.
Important Facts for Investors to Verify
- Confirm the issuer identity: the supplied filing is for Blade Air Mobility, Inc., not Strata Critical Medical, Inc.
- Assess the sustainability of the 187% revenue growth, particularly the contribution from Trinity and Helijet acquisitions.
- Monitor gross margin, since cost of revenue increased faster than revenue and the company remains materially loss-making.
- Evaluate cash burn against the $266.6 million short-term investment balance and management’s statement that liquidity is sufficient for at least 12 months.
- Review the $28.8 million warrant liability and potential share dilution from 14.2 million warrants, 8.0 million options, and 2.5 million restricted shares.
- Track remediation of the material weakness in internal control over financial reporting, which management expected to address during 2022.
- Review capacity purchase commitments and the April 2022 amendment for potential fixed-cost exposure if demand weakens.
- Consider seasonality, Omicron and other pandemic effects, aircraft operator concentration, aviation regulation, and electric vertical aircraft certification risk.